# Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

> **NCT00388882** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 327 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** tiotropium
- **DRUG:** ipratropium bromide / albuterol

## Key facts

- **NCT ID:** NCT00388882
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-04
- **Primary completion:** 2007-10-08
- **Final completion:** —
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00388882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00388882, "Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00388882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*